openPR Logo
Press release

Digital Landscape: Inflammatory Bowel Disease Market

09-21-2018 12:08 PM CET | Health & Medicine

Press release from: ReportsnReports

Inflammatory Bowel Disease

Inflammatory Bowel Disease

The Digital Landscape Inflammatory Bowel Disease market report analyzes digital activities undertaken by pharma in support of disease-modifying therapies for mild-to-moderate, and moderate-to-severe Crohn’s disease and ulcerative colitis (UC).

Key Highlights

- US Patients: AbbVie offers the strongest support for IBD patients in the US, particularly branded, unbranded and mobile app. Janssen was the most active competitor in the branded and social media spaces in 2017. Branded activity also seen from pipeline and biosimilar competitors. No IBD-specific mobile apps detected from pharma. Opportunity exists for a well-integrated unbranded campaign to support patients, linked to social media and a mobile app.

Get Free Sample Research Report at https://www.reportsnreports.com/contacts/requestsample.aspx?name=1653851

- US HCPs: Good support available for US HCPs in the IBD branded space, with Stelara and Humira activity detected from Janssen and AbbVie in 2017, respectively. Unbranded and mobile app landscapes are sparse. Opportunities may exist to develop or sponsor content with trusted non-pharma organizations; social media activity restricted to corporate accounts.

- EUCAN Patients: Good brand support for patients in Germany, the UK, and Canada, with IBD-specific activity detected from Takeda and Janssen in 2017. No multi-country unbranded from biologics manufacturers with Ferring providing the only example. Unbranded support is strongest in Germany overall, with new sites launched by Janssen and Pfizer in 2017. Social media support is weak overall; EUCAN IBD patients have access to good mobile app offerings, however none detected in Italy.

- EUCAN HCPs: The EUCAN HCP landscape is underdeveloped. Most branded activity limited to Germany or the UK with all new activity seen in the UK in 2017. The unbranded and mobile app landscapes are particularly sparse, and partnerships with non-pharma organizations may offer more effective opportunities to engage with and support HCPs.

Get Discount on this Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1653851

Scope

- This report analyzes digital activities undertaken by pharma in support of therapies for disease-modifying therapies for mild-to-moderate, and moderate-to-severe Crohn’s disease and ulcerative colitis (UC).
- The report includes digital activities directed towards patients and/or HCPs, including branded websites, unbranded disease awareness initiatives, social media and mobile apps.
- The report is based on analysis conducted by a combination of GlobalData’s digital and disease-specific teams. It also includes analysis of data licensed from third parties e.g. website traffic, search engine optimization (SEO), digital display advertising, mobile app downloads, and social media interaction.
- The geographic scope of the report is the United States, Canada and the 5EU (UK, Germany, France, Italy & Spain), with EUCAN used as an abbreviation for Europe and Canada throughout.
- This report covers the research period from January - December 2017.

Direct Purchase of Digital Landscape: Inflammatory Bowel Disease market research report at https://www.reportsnreports.com/purchase.aspx?name=1653851

Reasons to buy

- Our Digital Landscape report provides an analysis of pharma multichannel activity in the digital IBD space, and can assist our pharma clients derive value in a number of ways -
- Competitive Intelligence: Track and compare key competitor activity across channels and identify key trends in IBD
- Digital Strategy: Strengthen corporate digital excellence, learn from industry best practice, and identify opportunities for novel digital campaigns
- Support new brand launch: See best practice examples of pre- and post-launch digital activities, ascertain must-have digital assets for patient and HCP engagement, and assess potential gaps and opportunities for pipeline brands
- Business Development & Licensing: Assess topics and trends shaping digital health in IBD and beyond, and learn about key patient and physician online activities in IBD.

Table of Contents
Executive Summary
Recent Developments
Landscape & Analysis
US: Patient-directed Activities
US HCP-directed Activities
EUCAN Patient-directed Activities
EUCAN HCP-directed Activities
Methodology

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

+ 1 888 391 5441
sales@reportsandreports.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Digital Landscape: Inflammatory Bowel Disease Market here

News-ID: 1254398 • Views: 163

More Releases from ReportsnReports

Cardiac Mapping Market 2019 Global Industry Extensive Competitive Landscape on S …
2019 Research Report on Global Cardiac Mapping Market is a professional and comprehensive report on the Cardiac Mapping industry. #Download Free PDF Sample Brochure of report Global Cardiac Mapping Market 2019 across with 135 Pages and in-depth TOC Analysis @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=2851197 Key Players: Biosense Webster (US), Abbott (US), Medtronic (Ireland), Boston Scientific Corporation (US), MicroPort Scientific Corporation (China), EP Solutions SA (Switzerland), Acutus Medical (US), Koninklijke Philips N.V. (Royal
Bed Monitoring System & Baby Monitoring System Market Size, Overview, Risk, and …
2019 Research Report on Global Bed Monitoring System & Baby Monitoring System Market is a professional and comprehensive report on the Bed Monitoring System & Baby Monitoring System industry. #Download Free PDF Sample Brochure of report Global Bed Monitoring System & Baby Monitoring System Market 2019 across with 86 Pages and in-depth TOC Analysis @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=2288608 Key Players: Early Sense (US), EMFIT (Finland), Eight Sleep (US), Smart Caregiver Corporation (US),
Bio Decontamination Market - Global Industry Analysis, Size, Share, Growth, Tren …
2019 Research Report on Global Bio Decontamination Market is a professional and comprehensive report on the Bio Decontamination industry. #Download Free PDF Sample Brochure of report Global Bio Decontamination Market 2019 across with 110 Pages and in-depth TOC Analysis @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=2304323 Key Players: STERIS (US), Ecolab, Inc. (US), TOMI Environmental Solutions, Inc. (US), JCE Biotechnology (France), Fedegari Autoclavi SpA (Italy), Zhejiang Tailin Bioengineering Co., Ltd. (China), Noxilizer, Inc. (US), Howorth
Lancets Market 2019 - Business Size, Share, Opportunities, Future Trends, Top Ke …
2019 Research Report on Global Lancets Market is a professional and comprehensive report on the Lancets industry. #Download Free PDF Sample Brochure of report Global Lancets Market 2019 across with 107 Pages and in-depth TOC Analysis @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=2318667 Key Players: Becton, Dickinson and Company (US), Roche Diagnostics (Switzerland), Ypsomed (Switzerland), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Own Mumford (UK), HTL-STREFA S.A (Poland), ARKRAY (Japan), Sarstedt (Germany), and SteriLance Medical

All 5 Releases


More Releases for IBD

Physician Perspectives 2017: Ustekinumab in IBD Therapeutics Poses Superlative O …
Inflammatory bowel disease (IBD) is an acute digestive disorder characterized by severe digestive tract inflammation. Increased occurrences of IBD maladies such as Crohn's disease has instigated massive research initiatives in therapeutics development of IBD. Significant advances towards deve lopment of alternative therapeutics such as ustekinumab as a potential substitute for prevalent therapeutics such as anti-TNF therapy is likely to direct new growth roadmap for ustekinumab in IBD therapeutics. Anti-TNF therapy has
Global E-Scooters Market Outlook 2018-2025 : Aodi, Pedego, Elio, IBD, Ford, Jinh …
Global “E-Scooters Market 2018” Industry Share, Growth, Research, Analysis, Development Trends, Demands, and Forecasts. The Global E-Scooters Market report is crafted by executing an outstanding research process to gather key statistics of the Global E-Scooters Market. The research analysis is based on two sections, particularly, primary research and extensive secondary research. Secondary research includes a practical market review and segmentation of the Global E-Scooters Market. It also highlights important players in
Global Inflammatory Bowel Disease (IBD) Treatment Market to Grow at 2.6% CAGR th …
A new thorough study titled “Inflammatory Bowel Disease (IBD) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025” has recently been submitted to the database of Market Research Reports Search Engine (MRRSE). The global inflammatory bowel disease treatment market is projected to grow at 2.6% CAGR through 2025. In terms of revenue, the market is anticipated to reach nearly US$ 15 Bn in revenues. Download
Inflammatory Bowel Disease (IBD) Treatment Market will Exhibit a Steady 2.6% CAG …
Competition is expected to remain high from 2017 to 2025 in the global inflammatory bowel disease (IBD) treatment market. During this time, the market will witness a slew of launches as manufacturers invest in the development of novel therapeutics. According to a new study by Transparency Market Research (TMR), a paradigm shift toward biosimilar and biologic drugs is expected, which will offer a fresh burst of opportunities to the global
Global Inflammatory Bowel Disease (IBD) Treatment Market to Grow at 2.6% CAGR th …
A new thorough study titled “Inflammatory Bowel Disease (IBD) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025” has recently been submitted to the database of Market Research Reports Search Engine (MRRSE). The global inflammatory bowel disease treatment market is projected to grow at 2.6% CAGR through 2025. In terms of revenue, the market is anticipated to reach nearly US$ 15 Bn in revenues. Request Sample Copy
Inflammatory Bowel Disease (IBD) Treatment Market to See Significant Growth in t …
A latest research report titled as “Inflammatory Bowel Disease (IBD) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the present state and future prospect for the global market. It provides valuable information to the industry insiders,